Le Lézard
Classified in: Health
Subject: v

Extendicare Announces April 2023 Dividend of C$0.04 per Share


MARKHAM, Ontario, April 17, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of April 2023, which is payable on May 15, 2023 to shareholders of record at the close of business on April 28, 2023. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors population. We operate or provide contract services to a network of 103 long-term care homes and retirement communities (53 owned/50 contract services), provide approximately 9.2 million hours of home health care services annually, and provide group purchasing services to third parties representing approximately 109,700 beds across Canada. Extendicare proudly employs approximately 18,000 qualified, highly trained and dedicated individuals who are passionate about providing high quality care and services to help people live better.

Forward-looking Statements

Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated future events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, growth strategy, results of operations and financial condition. Forward-looking statements can often be identified by the expressions "anticipate", "believe", "estimate", "expect", "intend", "objective", "plan", "project", "will", "may", "should" or other similar expressions or the negative thereof. These forward-looking statements reflect the Company's current expectations regarding future results, performance or achievements and are based upon information currently available to the Company and on assumptions that the Company believes are reasonable. The Company assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Company to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare's forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare's website at www.extendicare.com

Extendicare contact:

Jillian E. Fountain
Vice President, Investor Relations
T: (905) 470-5534
E: [email protected] 
www.extendicare.com 



These press releases may also interest you

at 08:41
In an effort to assist mass tort law firms connect with victims of allegedly dangerous Bard port catheters, Advocate Rights Center proudly announces the release of a groundbreaking guide tailored for mass tort intake call center agents and marketers:...

at 08:38
Regen Wellness is proud to announce they now offer the healthy skin rejuvenation of microneedling. Microneedling has quickly gained popularity as a natural and effective option for skin rejuvenation. This minimally invasive procedure involves using a...

at 08:35
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced positive topline results from a U.S. pivotal nasolabial fold (NLF) study of dermal filler products Evolyssetm Lift and...

at 08:35
HeartBeam, Inc. , a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new study data demonstrating that HeartBeam AI combined with vectorcardiography (VCG) outperformed an...

at 08:33
The National Comprehensive Cancer Network® (NCCN®) today announced publication of new NCCN Guidelines for Patients®: Small Bowel Adenocarcinoma. This free resource for people facing cancer and caregivers is focused on a rare cancer type that...

at 08:32
Butterfly Kisses Ultrasound Imaging Center is thrilled to announce the opening of its new location in Swedesboro, NJ! This cutting-edge facility offers expectant parents an unparalleled ultrasound imaging experience, creating a comfortable and...



News published on and distributed by: